首页> 外文OA文献 >Singleversustandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trial

【2h】

Singleversustandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trial

机译：单versustandem高剂量melphalan，然后是多发性骨髓瘤的自体血液干细胞移植：III期GMMG-HD2试验的长期结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Elias K. Mai; Axel Benner; Uta Bertsch; Peter Brossart; Annette Hänel; Volker Kunzmann; Ralph Naumann; Kai Neben; Gerlinde Egerer; Anthony D. Ho; Jens Hillengass; Marc S. Raab; Andreas Neubauer; Astrid Peyn; Yon-Dschun Ko; Norma Peter; Christof Scheid; Hartmut Goldschmidt;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trial [J] . Mai Elias K., Benner Axel, Bertsch Uta, British Journal of Haematology . 2016,第5期

机译：单剂量与串联大剂量美法仑，然后进行自体血干细胞移植治疗多发性骨髓瘤：III期GMMG-HD2试验的长期结果
2. High-dose chemotherapy plus autologous stem-cell transplantation as consolidation therapy in patients with relapsed multiple myeloma after previous autologous stem-cell transplantation (NCRI Myeloma X Relapse [Intensive trial]): A randomised, open-label, phase 3 trial [J] . CookG., WilliamsC., BrownJ.M., The lancet oncology . 2014,第8期

机译：大剂量化疗加自体干细胞移植作为巩固疗法治疗先前自体干细胞移植后复发的多发性骨髓瘤患者（NCRI骨髓瘤X复发[强化试验]）：一项随机，开放标签的3期试验
3. Intensification Therapy with Bortezomib-Melphalan-Prednisone Versus Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma: An Intergroup, Multicenter, Phase III Study of the European Myeloma Network (EMN02/HO95 MM Trial) [J] . Cavo Michele, Beksac Meral, Dimopoulos Meletios A., Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：与硼替佐米 - 莫尔芬 - 泼尼松对新诊断的多发性骨髓瘤的增强治疗与自体干细胞移植：欧洲骨髓瘤网络（EMN02 / HO95MM试验）的杂项，多中心，第三阶段研究
4. Phase 1 Trial of Retroviral-Mediated Transfer of the Human MDR-1 In Patients Undergoing High-Dose Chemotherapy and Autologous Stem Cell Transplantation [C] . Charles Hesdorffer, Janet Ayello, Maureen Ward, Keio International Symposium for Life Sciences and Medicine . 2000

机译：逆转录病毒介导的人MDR-1转移的第1期试验在接受高剂量化疗和自体干细胞移植的患者中
5. Natural Killer Cell Recovery and Disease Outcomes After Autologous Stem Cell Transplantation in Multiple Myeloma [D] . Keruakous, Amany R. 2021

机译：自然杀手细胞回收和疾病结果在多发性骨髓瘤中的自体干细胞移植后
6. A Phase I Dose-Escalation Trial of High-Dose Melphalan with Palifermin for Cytoprotection Followed by Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Normal Renal Function [O] . Muneer H. Abidi, Rishi Agarwal, Nishant Tageja, -1

机译：高剂量Melphalan的I次升级试验具有颅骨保护性的paliferphin然后对多发性肾功能多发性骨髓瘤的患者进行自体干细胞移植
7. A Phase I Dose-Escalation Trial of High-Dose Melphalan with Palifermin for Cytoprotection Followed by Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Normal Renal Function [O] . Abidi Muneer H., Agarwal Rishi, Tageja Nishant, 2013

机译：肾功能正常的多发性骨髓瘤患者的大剂量美法仑加Palifermin进行细胞保护及自体干细胞移植的I期剂量递增试验

Singleversustandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trial

著录项

相似文献

相关主题

期刊订阅